Home > Drug Search >
  • Targets: Leptin receptor (LEPR)
  •   > 
Drug Filter
Category:
chemistry (18) biology (3)
Status:
Approved (8) Phase Ⅲ (2) Phase Ⅱ (6) Phase Ⅰ (5)
Clinical Stage:
Active (9) Discontinued (4)
Bio-Type:
Recombinant polypeptide (1) Recombinant hormone (1) Whole antibody (1)
Company:
Daiichi Sankyo (1) Exelixis (1) Ferring Pharmaceuticals (1) Helsinn (1) Lilly (1) Mitsubishi Tanabe Pharma (1) Nycomed Pharmaceutical (1) Pfizer (3) Shionogi (1) Shire (1) Takeda (1) Unknown (4) Shandong KBP BioSciences (1) Seikagaku (1) GLyPharma (1) Amylin Pharmaceutical (1) Biotie (1) Zealand Pharma (1) Abide Therapeutics (1) KBP Biosciences USA (1) Aegerion (1) AstraZeneca (2) Bayer (2) Bristol-Myers Squibb (1)
Indication:
Oedema (1) Orthostatic hypotension (1) Congestive heart failure (3) Adrenocortical insufficiency (2) Diabetic nephropathy (6) Diarrhea (1) Epilepsy/Seizures (1) Heart failure (1) Hypertension (6) Rheumatoid arthritis (RA) (1) Type 2 diabetes (1) Chronic kidney disease (1) Hypokalaemia (1) Chronic heart failure (1) Contraception (1) Primary sclerosis cholangitis (1) Short bowel syndrom (1) Congenital adrenal hyperplasia (1) Plaque psoriasis (1) Gastrointestinal disorders (1) Lipodystrophy (1) Primary aldosteronism (1) Neurological disease (1) Skin disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top